Dr. Shannon E. Boye
Shannon Boye graduated with a Ph.D in Neuroscience from the University of Florida in 2006. She is now a tenured full Professor and Chief of the Division of Cellular and Molecular Therapy in the Department of Pediatrics at the University of Florida. The focus of her research is developing viral vector-based gene therapies for the treatment of inherited ocular disease. She has multiple awarded and pending patents emanating from her research program, and is actively funded by the NIH, private foundations, and pharma. She is the recipient of several major awards including the Foundation Fighting Blindness’s Board of Director’s Award, the Gund Harrington Scholar Award, the ARVO Foundation/Merck Innovative Ophthalmology Research Award, and the ARVO/Pfizer Carl Camras Translational Research Award. Since 2010, she has given over 70 invited lectures both within and outside the USA. She is also co-Founder, Director, and Chief Scientific Officer of Atsena Therapeutics, a clinical stage gene therapy company based in Durham, North Carolina. Outside of her research, she is actively involved in the teaching mission of the College of Medicine at the University of Florida and is passionate about outreach/education outside the University. She routinely provides lab tours for visually impaired patients, hosts foundation meetings and educates patients about ongoing research being conducted to address treatments for their conditions.
Graduate Students
Biological Scientists
Co-Investigators